Biological Therapy Analysis & Statistics, December 2014 (p6)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

151-180 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Australia, Oceania
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : India, Asia
PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • December 2014
  • by Global Data

Rituxan/Mabthera (rituximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biological Therapy, Pathology, Biotechnology
  • Countries : World
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • $ 4 995
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Acute Spinal Cord Injury - Pipeline Review, H2 2014

Acute Spinal Cord Injury - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Acute Spinal Cord Injury - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Acute Spinal Cord Injury - Pipeline Review, H2 2014’, provides an overview of the Acute Spinal Cord Injury’s ...

  • Industries : Pathology
  • Countries : United States
TiGenix NV - Product Pipeline Review - 2014

TiGenix NV - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

TiGenix NV - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘TiGenix NV - Product Pipeline Review - 2014’, provides an overview of the TiGenix NV’s pharmaceutical research and ...

  • Industries : Research and Development, Biological Therapy
  • Countries : Spain, World
Oligodendroglioma - Pipeline Review, H2 2014

Oligodendroglioma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Oligodendroglioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2014’, provides an overview of the Oligodendroglioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Febrile Neutropenia Global Clinical Trials Review, H2, 2014

Febrile Neutropenia Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • December 2014
  • by Global Data

Febrile Neutropenia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2014" provides data on the Febrile Neutropenia ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Paralysis - Pipeline Review, H2 2014

Paralysis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Paralysis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Paralysis - Pipeline Review, H2 2014’, provides an overview of the Paralysis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Leukodystrophies - Pipeline Review, H2 2014

Leukodystrophies - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Leukodystrophies - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Leukodystrophies - Pipeline Review, H2 2014’, provides an overview of the Leukodystrophies’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States, World
Articular Cartilage Defect - Pipeline Review, H2 2014

Articular Cartilage Defect - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Articular Cartilage Defect - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Articular Cartilage Defect - Pipeline Review, H2 2014’, provides an overview of the Articular Cartilage Defect’s ...

  • Industries : Biological Therapy
  • Countries : United States, World
Muscular Dystrophy - Pipeline Review, H2 2014

Muscular Dystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Muscular Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Muscular Dystrophy’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
DaVinci Biosciences, LLC - Product Pipeline Review - 2014

DaVinci Biosciences, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

DaVinci Biosciences, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘DaVinci Biosciences, LLC - Product Pipeline Review - 2014’, provides an overview of the DaVinci Biosciences, ...

  • Industries : Pathology, Research and Development, Biological Therapy, General Medicine and Specialty Medicine
  • Countries : World
Celladon Corporation - Product Pipeline Review - 2014

Celladon Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Celladon Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Celladon Corporation - Product Pipeline Review - 2014’, provides an overview of the Celladon Corporation’s ...

  • Industries : Pathology, Biological Therapy, General Medicine and Specialty Medicine
  • Countries : United States
Stratatech Corporation - Product Pipeline Review - 2014

Stratatech Corporation - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Stratatech Corporation - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Stratatech Corporation - Product Pipeline Review - 2014’, provides an overview of the Stratatech Corporation’s ...

  • Industries : Biological Therapy, Research and Development, Medical Equipment and Supply
  • Countries : United States
Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Primary Immune Deficiency (PID) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H2 2014’, provides an overview of the Primary Immune ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2014

Osteonecrosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Osteonecrosis - Pipeline Review, H2 2014’, provides an overview of the Osteonecrosis’s therapeutic pipeline. This report ...

  • Industries : Pathology, Biological Therapy, Therapy, Pharmaceutical
  • Countries : United States, World, United Kingdom
Vasculitis - Pipeline Review, H2 2014

Vasculitis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Vasculitis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Vasculitis - Pipeline Review, H2 2014’, provides an overview of the Vasculitis’s therapeutic pipeline. This report provides ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
The Market for Personalized Gene Therapy Treatments for Cancer

The Market for Personalized Gene Therapy Treatments for Cancer

  • $ 3 995
  • Industry report
  • December 2014
  • by Kalorama Information

This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach in cancer research. It involves modification ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Biological Therapy, Pharmaceutical, Healthcare
  • Countries : United States, World
Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

  • $ 2 838
  • Industry report
  • December 2014
  • by La Merie Publishing

Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants A Pipeline Landscape Analysis and Comparative ...

  • Industries : Pathology, Biopharmaceutical
  • Countries : United States
Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Tissue Therapies Limited (TIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • December 2014
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a biomedical technology company. The company develops biomedical technologies for tissue repair, wound healing and cell culture applications. It develops treatments ...

  • Industries : Biological Therapy
Global Regenerative Medicine Market 2015-2019

Global Regenerative Medicine Market 2015-2019

  • $ 2 500
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Regenerative Medicines Regenerative medicine deals with the process of using therapeutically induced or laboratory-grown human tissue to treat injured or diseased human cells, tissues, or organs. ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : World
Cellectis S.A. - Product Pipeline Review - 2014

Cellectis S.A. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Cellectis S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Cellectis S.A. - Product Pipeline Review - 2014’, provides an overview of the Cellectis S.A.’s pharmaceutical research ...

  • Industries : Research and Development, Pathology, Biopharmaceutical
  • Countries : World
Erytech Pharma SA - Product Pipeline Review - 2014

Erytech Pharma SA - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Erytech Pharma SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Erytech Pharma SA - Product Pipeline Review - 2014’, provides an overview of the Erytech Pharma SA’s pharmaceutical ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Research and Development, Pharmaceutical
  • Countries : South Africa, Saudi Arabia
NeoStem, Inc. - Product Pipeline Review - 2014

NeoStem, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘NeoStem, Inc. - Product Pipeline Review - 2014’, provides an overview of the NeoStem, Inc.’s pharmaceutical research ...

  • Industries : Biological Therapy, Pathology, Research and Development
  • Countries : United States
Immune Design Corp. - Product Pipeline Review - 2014

Immune Design Corp. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Immune Design Corp. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Immune Design Corp. - Product Pipeline Review - 2014’, provides an overview of the Immune Design Corp.’s pharmaceutical ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Research and Development
  • Countries : United States
Malignant Glioma - Pipeline Review, H2 2014

Malignant Glioma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Malignant Glioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Glioma’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Retinal Degeneration - Pipeline Review, H2 2014

Retinal Degeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Retinal Degeneration - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Retinal Degeneration - Pipeline Review, H2 2014’, provides an overview of the Retinal Degeneration’s therapeutic ...

  • Industries : Pathology, Research and Development, Pharmaceutical
  • Countries : World, United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.